Frankfurt - Delayed Quote EUR
Ovid Therapeutics Inc. (1OT.F)
0.2260
+0.0300
+(15.31%)
At close: 8:06:17 AM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALEXANDER MARGARET A. President | Sale | Feb 26, 2025 | 73,406 |
| LEVIN JEREMY M Chief Executive Officer | Purchase | Mar 18, 2024 | 3,652,180 |
| PERONE THOMAS MICHAEL General Counsel | Stock Award(Grant) | Feb 22, 2024 | 28,125 |
| RONA JEFFREY A Chief Financial Officer | Sale | Feb 26, 2025 | 67,973 |
| TARDIO JASON Chief Operating Officer | Stock Award(Grant) | Feb 22, 2024 | 28,125 |
Related Tickers
603233.SS DaShenLin Pharmaceutical Group Co., Ltd.
17.46
+0.34%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1900
+1.19%
1VT.MU Viking Therapeutics Inc
22.84
+2.10%
EXOZ eXoZymes, Inc.
12.05
-10.94%
AVBP ArriVent BioPharma, Inc.
21.17
+0.43%
RAPP Rapport Therapeutics, Inc.
11.10
-2.46%
MBX MBX Biosciences, Inc.
9.27
+3.11%
DSGN Design Therapeutics, Inc.
4.2400
+4.18%
SEPN Septerna, Inc.
6.46
+5.21%
ACXP Acurx Pharmaceuticals, Inc.
0.4017
+3.80%